Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATXI Avenue Therapeutics Inc.

Market Closed 02-14 16:00:00 EST

1.36

+0.00

0.00%

盘后1.31

-0.05-3.68%

19:14 EST

High1.39	Low1.33	Vol107.39K
Open1.36	D1 Closing1.36	Amplitude4.38%
Mkt Cap2.79M	Tradable Cap1.75M	Total Shares2.05M
T/O145.22K	T/O Rate8.35%	Tradable Shares1.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ATXI","market":"US","secType":"STK","nameCN":"Avenue Therapeutics Inc.","latestPrice":1.36,"timestamp":1739566800000,"preClose":1.36,"halted":0,"volume":107390,"hourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.36,"latestTime":"19:14 EST","volume":3883,"amount":5299.0873,"timestamp":1739578468712},"delay":0,"floatShares":1286460,"shares":2053923,"eps":-28.402174,"marketStatus":"Market Closed","change":0,"latestTime":"02-14 16:00:00 EST","open":1.36,"high":1.3897,"low":1.3301,"amount":145222.133147,"amplitude":0.043824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-28.402174,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1497585600000,"exchange":"NASDAQ","adjPreClose":1.36,"preHourTrading":{"tag":"盘前","latestPrice":1.35,"preClose":1.36,"latestTime":"08:00 EST","volume":2,"amount":2.7,"timestamp":1739538000339},"postHourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.36,"latestTime":"19:14 EST","volume":3883,"amount":5299.0873,"timestamp":1739578468712},"volumeRatio":1.730711028567304},"requestUrl":"/m/hq/s/ATXI","defaultTab":"news","newsList":[{"id":"2489512608","title":"Avenue Therapeutics files $35M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2489512608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489512608?lang=en_us&edition=fundamental","pubTime":"2024-12-05 06:20","pubTimestamp":1733350818,"startTime":"0","endTime":"0","summary":"17:16 EST Avenue Therapeutics (ATXI) files $35M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avenue-therapeutics-files-35m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avenue-therapeutics-files-35m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","ATXI","BK4139"],"gpt_icon":0},{"id":"2489125925","title":"Avenue Therapeutics Inc Files for Mixed Shelf of Upto $35 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2489125925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489125925?lang=en_us&edition=fundamental","pubTime":"2024-12-05 06:15","pubTimestamp":1733350509,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATXI","BK4007"],"gpt_icon":0},{"id":"2487516915","title":"BRIEF-Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)","url":"https://stock-news.laohu8.com/highlight/detail?id=2487516915","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487516915?lang=en_us&edition=fundamental","pubTime":"2024-11-30 07:10","pubTimestamp":1732921856,"startTime":"0","endTime":"0","summary":"BRIEF-Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550Nov 29  - Avenue Therapeutics Inc ATXI.O:AVENUE THERAPEUTICS INC - RECEIVES DELIST LETTER FROM NASDAQ UNDER NASDAQ LISTING RULE 5550Source text: [ID:n0001104659-24-124081]Further company coverage: ATXI.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nFWN3N00QC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXI","BK4007"],"gpt_icon":0},{"id":"2483172835","title":"Maxim Group Remains a Buy on Avenue Therapeutics (ATXI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483172835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483172835?lang=en_us&edition=fundamental","pubTime":"2024-11-16 23:35","pubTimestamp":1731771309,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Avenue Therapeutics (ATXI – Research Report). The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-avenue-therapeutics-atxi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-remains-a-buy-on-avenue-therapeutics-atxi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATXI","BK4007"],"gpt_icon":0},{"id":"2483733732","title":"Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2483733732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483733732?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:05","pubTimestamp":1731618303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA2S0G1S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBIO","BK4007","ATXI"],"gpt_icon":0},{"id":"2483307983","title":"Avenue Therapeutics Inc: Qtrly Shr Loss $1.92","url":"https://stock-news.laohu8.com/highlight/detail?id=2483307983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483307983?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:05","pubTimestamp":1731618303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA2S0G1S:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATXI","BK4007","FBIO"],"gpt_icon":0},{"id":"2482197485","title":"Avenue Therapeutics Inc  expected to post a loss of 94 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482197485","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482197485?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:02","pubTimestamp":1731081754,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics Inc  expected to post a loss of94cents a share - Earnings Preview Avenue Therapeutics Inc ATXI.OQ ATXI.O is expected to show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF2AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXI","FBIO"],"gpt_icon":0},{"id":"2467777686","title":"Allarity Therapeutics Names Alexander Epshinsky CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2467777686","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467777686?lang=en_us&edition=fundamental","pubTime":"2024-09-13 23:32","pubTimestamp":1726241546,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics (ALLR) said Friday it appointed Alexander Epshinsky as chief financial officer, succeeding Joan Brown.The company said Epshinsky previously served as controller at Avenue Therapeutics (ATXI).","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALLR","LENZ","ATXI"],"gpt_icon":0},{"id":"2467777631","title":"Allarity Therapeutics Names Alexander Epshinsky CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2467777631","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467777631?lang=en_us&edition=fundamental","pubTime":"2024-09-13 23:32","pubTimestamp":1726241546,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["ALLR","BK4139","ALLR.AU","ATXI","BK4007"],"gpt_icon":0},{"id":"2467720879","title":"Allarity Therapeutics Names Alex Epshinsky Finance Chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2467720879","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467720879?lang=en_us&edition=fundamental","pubTime":"2024-09-13 21:04","pubTimestamp":1726232640,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics has Alex Epshinsky as its new finance chief.The Boston clinical-stage pharmaceutical company said Epshinsky most recently served as controller at Avenue Therapeutics.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATXI","ALLR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avenuetx.com","stockEarnings":[{"period":"1week","weight":0.1147},{"period":"1month","weight":-0.2842},{"period":"3month","weight":-0.2953},{"period":"6month","weight":-0.456},{"period":"1year","weight":-0.8769},{"period":"ytd","weight":-0.32}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.02773},{"month":2,"riseRate":0.25,"avgChangeRate":-0.092258},{"month":3,"riseRate":0.571429,"avgChangeRate":0.067877},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.168509},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.016327},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.057418},{"month":7,"riseRate":0.125,"avgChangeRate":-0.101087},{"month":8,"riseRate":0.375,"avgChangeRate":-0.057572},{"month":9,"riseRate":0.125,"avgChangeRate":0.144298},{"month":10,"riseRate":0.25,"avgChangeRate":-0.242638},{"month":11,"riseRate":0.375,"avgChangeRate":-0.04796},{"month":12,"riseRate":0.375,"avgChangeRate":0.061275}],"exchange":"NASDAQ","name":"Avenue Therapeutics Inc.","nameEN":"Avenue Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avenue Therapeutics Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avenue Therapeutics Inc.,ATXI,Avenue Therapeutics Inc.股票,Avenue Therapeutics Inc.股票老虎,Avenue Therapeutics Inc.股票老虎国际,Avenue Therapeutics Inc.行情,Avenue Therapeutics Inc.股票行情,Avenue Therapeutics Inc.股价,Avenue Therapeutics Inc.股市,Avenue Therapeutics Inc.股票价格,Avenue Therapeutics Inc.股票交易,Avenue Therapeutics Inc.股票购买,Avenue Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avenue Therapeutics Inc.(ATXI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avenue Therapeutics Inc.(ATXI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}